Latest News about AXSM
Recent news which mentions AXSM
From Benzinga
Why Is NeuroSense Therapeutics Surging By 70%? 46 Stocks Moving In Monday's Mid-Day Session
June 27, 2022
From Benzinga
From Benzinga
EV Stocks TSLA, NIO, RIVN See Price Targets Slashed
June 27, 2022
From InvestorPlace
Axsome Therapeutics Rallies 40% On FDA Product Label Proposal, But Analyst Remains Skeptical
June 27, 2022
Tickers
AXSM
From Benzinga
From InvestorPlace
U.S. Markets Open Lower; Durable Goods Orders Rise 0.7%
June 27, 2022
From Benzinga
Tesla's Up as Stock-Split Investors Wait, But This Tiny Nasdaq Stock Is Riding High Monday
June 27, 2022
From Motley Fool
From Benzinga
3 Stocks That Could Double by 2025
June 19, 2022
From Motley Fool
2 Top Biotech Stocks Ready for Bull Runs
June 15, 2022
From Motley Fool
From InvestorPlace
2 Under-the-Radar Biotech Stocks to Buy in 2022
May 18, 2022
From Motley Fool
2 Biotech Stocks That Could Go Parabolic
May 16, 2022
From Motley Fool
My Favorite Biotech
May 13, 2022
From Motley Fool
Why Axsome Therapeutics Stock Got Mashed on Monday
May 09, 2022
From Motley Fool
Jazz Pharmaceuticals Completes U.S. Divestiture Of Sunosi To Axsome Therapeutics, What's Next?
May 09, 2022
From Benzinga
92 Biggest Movers From Friday
May 09, 2022
From Benzinga
Tickers
AXSM
From Motley Fool
FDA Issues Complete Response Letter (CRL) to Axsome Therapeutics for AXS-07 In Acute Migraine
May 02, 2022
From Benzinga
From Benzinga
Earnings Scheduled For May 2, 2022
May 02, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.